[1]Machlowska J, Baj J, Sitarz M, et al. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies[J]. Int J Mol Sci, 2020,21:4012. doi:10.3390/ijms21114012. [2]Sugano K. Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis[J]. Gastric Cancer, 2019,22: 435-445. [3]Li J, Perez Perez GI. Is there a role for the non-Helicobacter pylori bacteria in the risk of developing gastric cancer?[J].Int J Mol Sci, 2018,19: 1-9. [4]Hu YL, Pang W, Huang Y, et al. The gastric microbiome is perturbed in advanced gastric adenocarcinoma identified through shotgun metagenomics[J]. Front Cell Infect Mi, 2018,8: 433. doi:10.3389/fcimb.2018.00433. [5]Coker OO, Dai Z, Nie Y, et al. Mucosal microbiome dysbiosis in gastric carcinogenesis[J]. Gut, 2018,67: 1024-1032. [6]Liu X, Shao L, Liu X, et al. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer[J]. EBioMedicine, 2019,40: 336-348. [7]Gantuya B, El Serag HB, Matsumoto T, et al. Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions[J]. Aliment Pharm Ther, 2020,51: 770-780. [8]Wang Z, Gao X, Zeng R, et al. Changes of the gastric mucosal microbiome associated with histological stages of gastric carcinogenesis[J]. Front Microbiol, 2020,11: 997.doi:10.3389/fmicb.2020.00997. [9]Ren R, Wang Z, Sun H, et al. The gastric mucosal-associated microbiome in patients with gastric polyposis[J]. Sci Rep, 2018,8: 13817. doi:10.1038/s41598-018-31738-2. [10]Li TH, Qin Y, Sham PC, et al. Alterations in gastric microbiota after H. pylori eradication and in different histological stages of gastric carcinogenesis[J]. Sci Rep, 2017,7: 44935.doi:10.1038/srep44935. [11]Jo HJ, Kim J, Kim N, et al. Analysis of gastric micro-biota by pyrosequencing: minor role of bacteria other than Helicobacter pylori in the gastric carcinogenesis[J]. Helicobacter, 2016,21: 364-374. [12]Yu G, Hu N, Wang L, et al. Gastric microbiota features associated with cancer risk factors and clinical outcomes: a pilot study in gastric cardia cancer patients from Shanxi, China[J]. Int J Cancer, 2017,141: 45-51. [13]Engstrand L, Graham DY. Microbiome and gastric cancer[J]. Dig Dis Sci, 2020,65: 865-873. [14]Chen XH, Wang A, Chu AN, et al. Mucosa-associated microbiota in gastric cancer tissues compared with non-cancer tissues[J]. Front Microbiol, 2019,10: 1261. doi:10.3389/fmicb.2019.01261. [15]Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota[J]. Gut, 2018,67: 226-236. [16]Fan X, Alekseyenko AV, Wu J, et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study[J]. Gut, 2018,67: 120-127. [17]Flemer B, Warren RD, Barrett MP, et al. The oral microbiota in colorectal cancer is distinctive and predictive[J]. Gut, 2018,67: 1454-1463. [18]Jakszyn P, Bingham S, Pera G, et al. Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study[J]. Carcinogenesis, 2006,27: 1497-1501. [19]Hsieh YY, Tung SY, Pan HY, et al.Increased abundance of clostridium and fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan[J]. Sci Rep, 2018,8: 158.doi:0.1038/s41598-017-18596-0. [20]Zhang X, Li C, Cao W, et al. Alterations of gastric microbiota in gastric cancer and precancerous stages[J]. Front Cell Infect Microbiol, 2021,11: 559148. doi:10.3389/fcimb.2021.559148. [21]Ippolito L, Morandi A, Giannoni E, et al. Lactate: a metabolic driver in the tumour landscape[J]. Trends Biochem Sci, 2019,44: 153-166. [22]Nomura M, Nagatomo R, Doi K, et al.Association of short-chain fatty acids in the gut microbiome with clinical response to treatment with nivolumab or pembrolizumab in patients with solid cancer tumors[J]. JAMA Network Open, 2020,3: e202895. doi:10.1001/jamanetworkopen.2020.2895. [23]Yin J, Ren W, Huang X, et al. Potential mechanisms connecting purine metabolism and cancer therapy[J]. Front Immunol, 2018,9: 1697. doi:10.3389/fimmu.2018.01697. [24]Sheikh A, Taube J, Greathouse KL. Contribution of the microbiota and their secretory products to inflammation and colorectal cancer pathogenesis: the role of toll-like receptors[J]. Carcinogenesis, 2021,42:1133-1142. [25]Lofgren JL, Whary MT, Ge Z, et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia[J]. Gastroenterology, 2011,140: 210-220. |